top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

London Biotechnology Show_Register Now.png

Popular Content.

PHARMA

Innovent Biologics and Pfizer Forge $10.5 Billion Oncology Partnership

Strategic collaboration combines Innovent’s early-stage oncology innovation platform with Pfizer’s global development and commercial capabilities across 12 cancer programs.

 Featured Articles. 

7-format11240.jpg
HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

7-format11240.jpg
BIOTECH

UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up and it's Just Recruited its First Patients

7-format11240.jpg
SUSTAINABILITY

Engineering Crops From the Inside Out

7-format11240.jpg
PHARMA

AI in Science Writing and the Imitation of Understanding

7-format11240.jpg
PHARMA

Pharma & Biotech Quality Summit 2026

7-format11240.jpg
BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

7-format11240.jpg
BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

7-format11240.jpg
PHARMA

Inside Nxera Pharma’s Next-Generation Biopharma Model

7-format11240.jpg
BIOTECH

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

 Latest News. 

29th May, 2026

01.

Innovent Biologics and Pfizer Forge $10.5 Billion Oncology Partnership

Strategic collaboration combines Innovent’s early-stage oncology innovation platform with Pfizer’s global development and commercial capabilities across 12 cancer programs.

28th May, 2026

02.

Combat Medical Highlights Patient Impact of HIVEC HEAT Trial at AUA 2026

Phase 3 HIVEC® HEAT study presented at AUA 2026 highlights progress toward FDA registration and the potential for bladder-preserving treatment in high-risk NMIBC patients.

20th May, 2026

03.

UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up

Cyclana Bio's PEMP study has received NHS ethics approval and begun enrolling women at two UK hospitals. If its tissue-first approach to drug discovery pays off, it could start answering questions that have gone unanswered for decades.

11th May, 2026

04.

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

A first-in-human trial for a tampon-like intravaginal drug delivery platform arrives at a moment when England's newly published Women's Health Strategy is calling for exactly this kind of patient-centred innovation.

Editor's Selects.

AI in Science Writing and the Imitation of Understanding

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

A Simple Pad Could Transform Cervical Cancer Screening

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

LivX_BANNERS_GIF_728 x 90.gif

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page